Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

Fig. 2

Feature selection for the potential markers associated with endpoints using the Boruta algorithm. A. The process of feature selection. B. The value evolution of Z-score in the screening process. The horizontal axis shows the name of variables and the number of iterations in Fig. 2-A and -B, respectively. While the vertical axis represents the Z-value of each variable, and the blue boxes and lines corresponds to the minimum, average, and maximum Z-scores for a shadow feature. The green boxes and lines represent confirmed variables, the yellow ones represent tentative attributes, and the red ones represent rejected variables in the model calculation. TyG, triglyceride-glucose; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; OMI, old myocardial infarction; CVD, cardiovascular disease; DES, drug-eluting stent; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blockers; Neu, neutrophil; Lym, lymphocyte; PLT, platelets; Hb, hemoglobin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Lp (a), lipoprotein (a); HCY, homocysteine; Hs-CRP, hypersensitive C-reactive protein; Scr, serum creatinine; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin; PAD, peripheral artery disease; baPWV, brachial-ankle pulse wave velocity; ABI, ankle-brachial index; FMD, brachial artery flow-mediated vasodilatation; LAD, left atrial diameter; LVEF, left ventricular ejection fraction; LVDd, left ventricular end-diastolic diameter; IVST, interventricular septal thickness; PWT, left ventricular posterior wall thickness

Back to article page